Rationale and design of the 'MITOCARE' study: A phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction

Cardiology (Switzerland)

Volumn 123, Issue 4, 2012, Pages 201-207

  Atar, Dan ^a   Abitbol, Jean Louis ^b   Arheden, Hakan ^c   Berdeaux, Alain ^d   Bonnet, Jean Louis ^e   Carlsson, Marcus ^c   Clemmensen, Peter ^f   Cuvier, Valérie ^b   Danchin, Nicolas ^g   Dubois Randé, Jean Luc ^h   Engblom, Henrik ^c   Erlinge, David ⁱ   Firat, Hü Seyin ^j   Jensen, Svend Eggert ^k   Halvorsen, Sigrun ^l   Hansen, Henrik Steen ^m   Heiberg, Einar ^c   Larsen, Alf Inge ⁿ   Le Corvoisier, Philippe ^h   Longlade, Pascal ^b   Nordrehaug, Jan Erik ^o   Perez, Carole ^b   Pruss, Rebecca ^b   Sonou, Gilles ^p   Schaller, Sophie ^b   Tuseth, Vegard ^o   Vicaut, Eric ^q   more..

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Trophos SA   (France)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^e TIMONE HOSPITAL   (France)

^f Rigshospitalet   (Denmark)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ LUND UNIVERSITY   (Sweden)

^j Firalis SAS   (France)

^k Aalborg Regional Laboratory   (Denmark)

^l OSLO UNIVERSITY HOSPITAL   (Norway)

^m ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁿ STAVANGER UNIVERSITY HOSPITAL   (Norway)

^o UNIVERSITY OF BERGEN   (Norway)

^p Mobile Health   (France)

^q Lariboisiae Hospital   (France)

more..

Author keywords

Acute myocardial infarction; EU FP7 grant; Percutaneous coronary intervention; Reperfusion injury; TRO40303

Indexed keywords

CARRIER PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; TRO40303; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; DRUG EFFICACY; DRUG SAFETY; HEART MUSCLE ISCHEMIA; HUMAN; INTENTION TO TREAT ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); MUSCLE ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUDY DESIGN;

EID: 84872077959     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000342981     Document Type: Article

References (29)

1. Yellon DM, Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135
2. Santoro GM, Carrabba N, Migliorini A, Parodi G, Valenti R: Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Heart Fail 2008; 10: 780-785
3. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M: Postconditioning the human heart. Circulation 2005; 112: 2143-2148 (Pubitemid 41475808)
4. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre- Fouet X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M: Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008; 359: 473-481
5. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Suselbeck T, Clemmensen PM, Marin-Galiano M, Geudelin B, Buser PT: Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 2009; 53: 720-729
6. Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Thibault H, Cung TT, Finet G, Argaud L, Revel D, Derumeaux G, Bonnefoy-Cudraz E, Elbaz M, Piot C, Ovize M, Croisille P: Postconditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012; 59: 2175-2181
7. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre- Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M: Longterm benefit of postconditioning. Circulation 2008; 117: 1037-1044
8. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial. Lancet 2010; 375: 727-734
9. Yang XC, Liu Y, Wang LF, Cui L, Wang T, Ge YG, Wang HS, Li WM, Xu L, Ni ZH, Liu SH, Zhang L, Jia HM, Vinten-Johansen J, Zhao ZQ: Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 2007; 19: 424-430 (Pubitemid 47509466)
10. Lonborg J, Kelbaek H, Vejlstrup N, Jorgensen E, Helqvist S, Saunamaki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrom T: Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 2010; 3: 34-41
11. Freixa X, Bellera N, Ortiz-Perez JT, Jimenez M, Pare C, Bosch X, De Caralt TM, Betriu A, Masotti M: Ischaemic postconditioning revisited: Lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012; 33: 103-112
12. Tarantini G, Favaretto E, Marra MP, Frigo AC, Napodano M, Cacciavillani L, Giovagnoni A, Renda P, De Biasio V, Plebani M, Mion M, Zaninotto M, Isabella G, Bilato C, Iliceto S: Postconditioning during coronary angioplasty in acute myocardial infarction: The POST-AMI trial. Int J Cardiol 2012, Epub ahead of print
13. Bordet T, Buisson B, Michaud M, Drouot C, Galea P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacapere JJ, Massaad C, Schumacher M, Steidl EM, Maux D, Delaage M, Henderson CE, Pruss RM: Identification and characterization of cholest-4-en- 3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther 2007; 322: 709-720 (Pubitemid 47105813)
14. Schaller S, Paradis S, Ngoh GA, Assaly R, Buisson B, Drouot C, Ostuni MA, Lacapere JJ, Bassissi F, Bordet T, Berdeaux A, Jones SP, Morin D, Pruss RM: TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J Pharmacol Exp Ther 2010; 333: 696-706
15. Baines CP: The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol 2009; 104: 181-188
16. Javadov S, Karmazyn M, Escobales N: Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 2009; 330: 670-678
17. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S: The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002; 39: 30-36 (Pubitemid 34059858)
18. Gibbons RJ, Miller TD, Christian TF: Infarct size measured by single photon emission computed tomographic imaging with (99m) Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation 2000; 101: 101-108 (Pubitemid 30039083)
19. Wright J, Bogaert J: Role of cardiac magnetic resonance imaging in ischaemic heart disease. Intern Med J 2009; 39: 563-573
20. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK: Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004; 25: 1940-1965 (Pubitemid 39452612)
21. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002 (Pubitemid 29529292)
22. Hedstrom E, Engblom H, Frogner F, Astrom- Olsson K, Ohlin H, Jovinge S, Arheden H: Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvage. J Cardiovasc Magn Reson 2009; 11: 38
23. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, Arai AE: Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006; 113: 1865-1870 (Pubitemid 43739398)
24. Carlsson M, Ubachs JF, Hedstrom E, Heiberg E, Jovinge S, Arheden H: Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: Quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging 2009; 2: 569-576
25. Sorensson P, Heiberg E, Saleh N, Bouvier F, Caidahl K, Tornvall P, Ryden L, Pernow J, Arheden H: Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson 2010; 12: 25
26. Ubachs JF, Sorensson P, Engblom H, Carlsson M, Jovinge S, Pernow J, Arheden H: Myocardium at risk by magnetic resonance imaging: Head-to-head comparison of T2- weighted imaging and contrast-enhanced steady-state free precession. Eur Heart J Cardiovasc Imaging 2012, DOI: 10.1093/ehjci/jes1091
27. Heiberg E, Ugander M, Engblom H, Gotberg M, Olivecrona GK, Erlinge D, Arheden H: Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: Animal, phantom, and human study. Radiology 2008; 246: 581- 588
28. Engblom H, Hedstrom E, Heiberg E, Wagner GS, Pahlm O, Arheden H: Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: One-year follow-up by MRI. Circ Cardiovasc Imaging 2009; 2: 47-55
29. Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schomig A, Schwaiger M: Acute myocardial infarction: Serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology 2010; 254: 88- 97